Cocchieri M, Chiuini E, Giaimo M D, Boschetti E, Solinas P
G Ital Cardiol. 1985 Mar;15(3):307-9.
We have undertaken the present study to evaluate the acute effects of propranolol and verapamil on the diastolic function in patients with hypertrophic cardiomyopathy. We used a non imaging isotope device, the nuclear stethoscope, that has been so far mainly employed for assessment of systolic function, although fitted for detecting diastolic filling rates and times as well. Relative cardiac output, ejection fraction, rapid and slow filling times and rates were measured in five patients suffering from hypertrophic cardiomyopathy in basal conditions and 10.20 and 30 minutes after i.v. administration for either propranolol or verapamil, with a time interval of at least 24 hours between the two acute drug studies. With respect to the baseline values only verapamil showed a significant improvement in rapid and maximum filling rates, suggesting that diastolic function is more beneficially affected by Ca-entry blockers rather than beta-blockers in hypertrophic cardiomyopathy.
我们开展了本研究,以评估普萘洛尔和维拉帕米对肥厚型心肌病患者舒张功能的急性影响。我们使用了一种非成像同位素设备——核听诊器,该设备迄今为止主要用于评估收缩功能,不过也适用于检测舒张期充盈率和时间。在5例肥厚型心肌病患者的基础状态下以及静脉注射普萘洛尔或维拉帕米后10、20和30分钟测量相对心输出量、射血分数、快速和缓慢充盈时间及速率,两次急性药物研究之间的时间间隔至少为24小时。与基线值相比,仅维拉帕米显示快速和最大充盈率有显著改善,这表明在肥厚型心肌病中,钙通道阻滞剂对舒张功能的影响比β受体阻滞剂更有益。